Matches in Nanopublications for { ?s ?p "bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical trial development and has shown promising results in clinical trials" ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- _5 value "bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical trial development and has shown promising results in clinical trials" provenance.
- _3 value "bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical trial development and has shown promising results in clinical trials" provenance.
- _5 value "bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical trial development and has shown promising results in clinical trials" provenance.
- _3 value "bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical trial development and has shown promising results in clinical trials" provenance.